ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY AGGRESSIVE NON HODGKIN LYMPHOMA WITH ACTIVE DISEASE

被引：0
|
作者：
Stasia, A. [1 ]
Bozzani, S. [1 ]
Parma, M. [2 ]
Pioltelli, P. [2 ]
机构：
[1] Univ Milano Bicocca, Osped San Gerardo Monza, Milan, Italy
[2] Osped San Gerardo, Monza, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1720
引用
收藏
页码：671 / 671
页数：1
相关论文
共 50 条
  • [41] Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Refractory Multiple Myeloma
    Ozturk, Hba
    Dikyar, Aa
    Yegin, Za
    Kaynar, La
    Can, F.
    Ozkurt, Zn
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2024, 27 (12) : 1405 - 1409
  • [42] Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma: Real World Experience of a Single Center
    Kopinska, A.
    Koclega, A.
    Wieczorkiewicz-Kabut, A.
    Wozniczka, K.
    Kata, D.
    Wlodarczyk, M.
    Helbig, G.
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [43] Nivolumab salvage therapy before and after allogeneic stem cell transplantation in relapsed/refractory hodgkin lymphoma
    Cheikh, J. E. I.
    Massoud, R.
    Abudalle, I.
    Haffar, B.
    Mahfouz, R.
    Kharfan-Dabaja, M. A.
    Jisr, T.
    Mougharbel, A.
    Ibrahim, A.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S30
  • [44] Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
    J A Yared
    N Hardy
    Z Singh
    S Hajj
    A Z Badros
    M Kocoglu
    S Yanovich
    E A Sausville
    C Ujjani
    K Ruehle
    C Goecke
    M Landau
    A P Rapoport
    Bone Marrow Transplantation, 2016, 51 : 850 - 852
  • [45] Salvage and disease control of aggressive histology non-Hodgkin's lymphoma by allogeneic stem cell transplantation
    Kuruvilla, J.
    Bao, Q.
    Suski, A.
    Gupta, V.
    Lipton, J. H.
    Minden, M. D.
    Messner, H. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 56 - 56
  • [46] Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience
    Nachbaur, D
    Oberaigner, W
    Fritsch, E
    Nussbaumer, W
    Gastl, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (01) : 43 - 49
  • [47] Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
    Yared, J. A.
    Hardy, N.
    Singh, Z.
    Hajj, S.
    Badros, A. Z.
    Kocoglu, M.
    Yanovich, S.
    Sausville, E. A.
    Ujjani, C.
    Ruehle, K.
    Goecke, C.
    Landau, M.
    Rapoport, A. P.
    BONE MARROW TRANSPLANTATION, 2016, 51 (06) : 850 - 852
  • [48] Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
    Rabitsch, W.
    Bojic, M.
    Wohlfarth, P.
    Leiner, M.
    Schoergenhofer, C.
    Kalhs, P.
    Schulenburg, A.
    Sillaber, C.
    Mitterbauer, M.
    Sperr, W. R.
    Jaeger, U.
    Skrabs, K.
    Greinix, H.
    Hermann, A.
    Lamm, W.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (06) : 1307 - 1314
  • [49] Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
    W. Rabitsch
    M. Bojic
    P. Wohlfarth
    M. Leiner
    C. Schörgenhofer
    P. Kalhs
    A. Schulenburg
    C. Sillaber
    M. Mitterbauer
    W. R. Sperr
    U. Jäger
    K. Skrabs
    H. Greinix
    A. Hermann
    W. Lamm
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1307 - 1314
  • [50] Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease
    Martin-Salces, M
    de la Guía, AL
    Hernández, D
    Kerguelén, A
    Cobo, T
    Canales, M
    G-Bustos, J
    Hernández-Navarro, F
    BONE MARROW TRANSPLANTATION, 2006, 37 : S323 - S323
12345